Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 16Lung Neoplasms 15Breast Neoplasms 4Sarcoma 2Rhabdomyosarcoma 2Prostatic Neoplasms 2Mesothelioma, Malignant 2Hodgkin Disease 2Adenocarcinoma of Lung 2Unspecified Adult Solid Tumor, Protocol Specific 1Rhabdomyosarcoma, Embryonal 1Rhabdomyosarcoma, Alveolar 1Recurrence 1Ovarian Neoplasms 1Neoplasms 1Malignant mesenchymal tumor 1Fatigue 1Breast Neoplasms, Male 1

Interventions

Trastuzumab 12Paclitaxel 10Taxes 9Doxorubicin 7Cyclophosphamide 7Docetaxel 6Bevacizumab 6Lapatinib 5Filgrastim 52,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 5Vorinostat 4tipifarnib 3pegfilgrastim 3cediranib 3Peripheral Blood Stem Cell Transplantation 3N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 3Carboplatin 3Capecitabine 3veliparib 2ixabepilone 2entinostat 2alvocidib 2Tamoxifen 2Radiotherapy 2Neoadjuvant Therapy 2MK 2206 2Interleukin-12 Subunit p35 2Interleukin-12 2Immunoenzyme Techniques 2Granulocyte Colony-Stimulating Factor 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Breast Neoplasms, Male × Vinorelbine × Clear all
NCT00017394 2013-01-17

Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer

National Cancer Institute (NCI)

Phase 2 Completed
56 enrolled
Breast

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡